Compass Therapeutics, Inc. announced that Stephen Squinto, Ph.D., a member of the Board of Directors, notified the Company of his resignation from the Board and all committees thereof, effective August 31, 2022. Dr. Squinto has been a member of the Board since 2015, when he joined representing an early investor in the Company and he is now moving on to pursue other professional endeavors.